Você esta aqui:Home > Cannabinoids (antigo) > Treating depression with cannabinoids
Cannabinoids 2008;3(2):8-10 (22 June 2008)
Original article
Treating depression with cannabinoids
Kurt Blaas
Lindengasse 27/10, 1070 Vienna, Austria, drblaas@blowdoc.at
Although a variety of drugs are available for the treatment of depression, therapy is not effective in all cases and finding alternative options is desirable. Results from animal studies, anecdotal ex-perience reported by patients using cannabis and observations from clinical studies where can-nabinoids were used in serious diseases suggest an anti-depressive potential of cannabinoid recep-tor agonists. From 2003 to 2006, 75 patients suffering from depression, stress and burnout syn-drome were successfully treated in a practice for general medicine with the cannabis ingredient dronabinol, alone or in combination with other antidepressants. Two case studies will be pre-sented. The presented observations suggest that dronabinol has an antidepressive potential that can readily be used in medical practice.
Keywords
Depression, burnout, cannabinoid, cannabis, dronabinol
Eventos Online 2020
Todas as informações sobre os Eventos IACM Online, incluindo vídeos gratuitos dos webinars com legendas em português, podem ser encontradas aqui.
Conferência 2022
A 12ª Conferência IACM sobre Canabinóides em Medicina será realizada nos dias 20 e 21 de Outubro de 2022 juntamente com o SSCM suíço em Basileia/Suíça.
Members only
Regular members can sign up for the new member area of the IACM to access exclusive content.
You need to become a regular member of the IACM to access the new member area.
IACM on Twitter
Follow us on twitter @IACM_Bulletin where you can send us inquiries and receive updates on research studies and news articles.